RGLS

Regulus Therapeutics
RGLS

Overview Fund Activity
Delisted

RGLS was delisted on the 24th of June, 2025.

Back to rankings

92 hedge funds and large institutions have $226M invested in Regulus Therapeutics in 2015 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 31 increasing their positions, 23 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
92
Holders Change
–
Holders Change %
0%
% of All Funds
2.57%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
16
Increased
31
Reduced
23
Closed
15
Calls
$11.4M
Puts
$3.97M
Net Calls
+$7.38M
Net Calls Change
-$6.95M

Top Buyers

1
Axa
1
Axa
France
$6.06M
2
FCMI
2
Foresite Capital Management II
California
$11.4M
3
UBS AM
3
UBS AM
Illinois
$14.5M
4
Susquehanna International Group
4
Susquehanna International Group
Pennsylvania
$2.5M
5
RCM
5
RA Capital Management
Massachusetts
$26.4M

Top Sellers

1
State Street
1
State Street
Massachusetts
$2.12M
2
Jennison Associates
2
Jennison Associates
New York
$0
3
Wellington Management Group
3
Wellington Management Group
Massachusetts
$27.6M
4
OIM
4
Oracle Investment Management
Connecticut
$2.45M
5
Goldman Sachs
5
Goldman Sachs
New York
$4.45M
Name Holding Trade Value Shares
Change 		Shares
Change %
PPA
101
Parametric Portfolio Associates
Washington
– -$150K -114 Closed
VAM
102
Verity Asset Management
North Carolina
– -$140K -107 Closed
HF
103
HRT Financial
New York
– -$139K -106 Closed
DTL
104
Dynamic Technology Lab
Singapore
– -$139K -106 Closed
Invesco
105
Invesco
Georgia
– -$6K -4 Closed
PCM
106
Prelude Capital Management
New York
– -$2K -2 Closed
1 2 3 4
5